This research indicates that Tau is a better marker of progression to Alzheimer’s disease than amyloid beta.
Learn More - Alzheimers Dementia Symptoms
Alzheimer's Reading Room
Subscribe to the Alzheimer's Reading Room
A buildup of plaque and dysfunctional proteins in the brain are hallmarks of Alzheimer’s disease.
While much Alzheimer’s research has focused on accumulation of the protein amyloid beta, researchers are starting to pay closer attention tau.
- Comparing brain images of people who are cognitively normal to patients with mild Alzheimer’s disease, the researchers found that measures of tau better predict symptoms of dementia than measures of amyloid beta.
- To determine the degree of cognitive impairment, some of the participants who underwent brain imaging, were assessed with the traditional clinical dementia rating (CDR) scale, cerebrospinal fluid measures, and widely used pen and paper tests of memory and other brain functions.
Need Answers to Your Questions About Alzheimer's and Caregiving?
“Our work and that of others has shown that elevated levels of amyloid beta are the earliest markers of developing Alzheimer’s disease. But in the earliest stages of Alzheimer’s disease, even with amyloid buildup, many patients are cognitively normal, meaning their memory and thought processes are still intact. What we suspect is that amyloid changes first and then tau, and it’s the combination of both that tips the patient from being asymptomatic to showing mild cognitive impairment.”
"While we currently cannot prevent or cure Alzheimer’s disease, delaying the onset of symptoms by 10-15 years would make a huge difference to our patients, to their families and caregivers, and to the global economy.”
- Beau M. Ances, MD, PhD, Washington University School of Medicine
The Connection Between UTI and Worsening Dementia
Coping with Dementia
What's the Difference Between Alzheimer's and Dementia
Test Your Memory for Dementia and Alzheimer's (5 Best Tests)
Alzheimer's Wandering Why it Happens and What to do
The study was published in the journal Science Translational Medicine.
"The Alzheimer's Reading Room and Bob DeMarco are true treasures to Alzheimer's patients and their loved ones, especially their caregivers. As a scientist I visit the site every day for the always current research updates."
"The world is incredibly fortunate to have this endless source of information and support. God bless you, Bob, and thanks for all you do!"
-- Rudy Tanzi Time Magazine's 100 most influential people in the world. Professor of Neurology and holder of the Joseph P. and Rose F. Kennedy Endowed Chair in Neurology at Harvard University.
The Alzheimer's Reading Room contains more than 5,000 articles and has been published daily since July, 2009.
You are reading original content the Alzheimer's Reading Room
Source: Brain imaging links Alzheimer’s decline to tau protein
Source: Brier M, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, et al. Tau and Ab Imaging CsF Measures, and Cognition in Alzheimer’s Disease. Science Translational Medicine. 2016.